MPR hits the quarter-century mark

Share this article:
Monthly Prescribing Reference (MPR) covered three new drugs for its inaugural issue, in June 1985. A quarter century and 906 new product editorials later, MPR is celebrating its 25th anniversary.   

Technology has been a key element in the publication's longevity, but MPR's most fundamental strength lies in its utility, said Lee Maniscalco, CEO at Haymarket Medical. “People rely on [MPR] because it's used, not read. They go to it for solutions.”

The concept for MPR, which offers concise editorial monographs (written by pharmacists) on new drugs, originated from MIMS, a similar drug reference title published in the UK, according to Mark Bugni, president and CEO of Prescribing Reference, Inc., a division of Haymarket Medical. In 1984, Haymarket execs Lindsay Masters and Simon Tindall brought the idea to the US, said Bugni, and were greeted with enthusiasm by pharma companies, agencies and even FDA personnel.

With Jerry Bernstein, MPR's first pharmacist editor, the publication developed its signature editorial style, tapping freelance pharmacists for content. One year later, MPR was being used by 40% of the US primary care audience, said Bugni, citing a FOCUS research study. The publication recognized the importance of third-party research early on, said Bugni. “Advertisers wanted to know how many times a doctor referred to the antihypertensive or migraine sections” to assess ad exposure, said Bugni.

Though the print issue still goes out each month, Jim Pantaleo, VP, publisher at MPR, said drug info has to reach physicians “in any form they need it, whenever and wherever, and that can be print, desktop, web or handheld.” MPR's format remains intact, and that is what users seek out, said Pantaleo. MPR is published by Haymarket Medical, a subsidiary of Haymarket Media, publisher of MM&M.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Headliner: HealthSpot's teleconnected CEO

Headliner: HealthSpot's teleconnected CEO

Steve Cashman, Founder and CEO, HealthSpot

Recruitment: The New Breed

Recruitment: The New Breed

What do healthcare agencies really want when it comes to potential employees? The answer to that question is in a constant state of flux, as technologies, clients' changing demands and ...

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the September 2014 issue of MM&M, with all text, charts and pictures.